Literature DB >> 20441394

Pathways through services for offenders with intellectual disability: a one- and two-year follow-up study.

William R Lindsay1, Tony Holland, Jessica R Wheeler, Derek Carson, Gregory O'Brien, John L Taylor, Lesley Steptoe, Claire Middleton, Karen Price, Susan Johnston, Steven J Young.   

Abstract

The pathways through services for offenders with intellectual disability were reviewed. Participants were 197 offenders with intellectual disability accepted into three types of community and three types of secure forensic intellectual disability services. They were first compared with 280 participants referred but not accepted into services and were then followed-up for 2 years to review pathways through services. Those accepted into services had a higher charge rate than did those who were referred (46% and 25%, respectively). The greatest diversity in pathway was seen in participants in community forensic intellectual disability and inpatient services. Individuals in secure settings showed the least diversity over time, and, similarly, a relatively high percentage of those accepted into generic community services remained in these services.

Entities:  

Mesh:

Year:  2010        PMID: 20441394     DOI: 10.1352/1944-7558-115.3.250

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  2 in total

1.  Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.

Authors:  Berit Bihlar Muld; Jussi Jokinen; Sven Bölte; Tatja Hirvikoski
Journal:  BMC Psychiatry       Date:  2013-12-13       Impact factor: 3.630

Review 2.  A systematic review and synthesis of outcome domains for use within forensic services for people with intellectual disabilities.

Authors:  Catrin Morrissey; Peter E Langdon; Nicole Geach; Verity Chester; Michael Ferriter; William R Lindsay; Jane McCarthy; John Devapriam; Dawn-Marie Walker; Conor Duggan; Regi Alexander
Journal:  BJPsych Open       Date:  2017-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.